| Title: |
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma |
| Authors: |
Kennedy, Oliver John a, b; Glassee, Nina c; Kicinski, Michal c; Blank, Christian U. d; Long, Georgina V. e; Atkinson, Victoria G. f; Dalle, Stéphane g; Haydon, Andrew M. h; Meshcheryakov, Andrey i; Khattak, Adnan j; Carlino, Matteo S. k; Sandhu, Shahneen l; Larkin, James m; Puig, Susana n; Ascierto, Paolo A. o; Rutkowski, Piotr p; Schadendorf, Dirk q; Boers-Sonderen, Marye r; Giacomo, Anna Maria Di s; van den Eertwegh, Alfonsus J.M. t; Grob, Jean-Jacques u; Gutzmer, Ralf v; Jamal, Rahima w; van Akkooi, Alexander C.J. x; Gandini, Sara y; Buhrer, Emanuel c; Suciu, Stefan c; Robert, Caroline z; Eggermont, Alexander M.M. aa, ab; Mandala, Mario ac; Lorigan, Paul b, ad, 1; Valpione, Sara b, ae, af, ⁎ |
| Source: |
In European Journal of Cancer April 2024 201 |
| Database: |
ScienceDirect |